Effects of hypertension on the outcomes of COVID-19: a multicentre retrospective cohort study
Zhong Li, Yuting Wu, Jinghua Gao, Jinxia Zhang, Qifeng Xie, Huang He, Jingjing Ji, Zheying Liu, Zheying Liu, Conglin Wang, Zhifeng Liu, Zhifeng Liu
Abstract
Hypertension does not affect the outcome of COVID-19, which is different than the conclusions drawn in other studies. However, the 28-day mortality and total 60-day mortality rates of hypertensive patients (age ≥ 70) with COVID-19 were significantly elevated, and compared with the group of survivors, non-surviving COVID-19 patients with hypertension were older, had more basic diseases and had a more severe clinical condition.
Topics & Concepts
MedicineBlood pressureCoronavirus disease 2019 (COVID-19)Internal medicineRetrospective cohort studyMortality rateMultivariate analysisStroke (engine)Odds ratioDiseaseCohort studyMechanical engineeringInfectious disease (medical specialty)EngineeringCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research